Sitagliptin T0242
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Sitagliptin, a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or in combination with metformin or thiazolidinedione for treatment of type 2 diabetes mellitus.
CAS nr:
486460-32-6
Purity:
98%
Molecular Weight:
407,32
SMILES:
C(=O)(C[C@@H](Cc1c(cc(c(c1)F)F)F)N)N1Cc2n(CC1)c(nn2)C(F)(F)F
Formula:
C16H15F6N5O
Pathway:
Proteases/Proteasome,Proteases/Proteasome,Ubiquitination,Autophagy
Target:
DPP-4,Proteasome,Proteasome,Autophagy
